NBY AMEX
NovaBay Pharmaceuticals, Inc.
1W: +25.3%
1M: +27.0%
3M: -93.6%
YTD: -93.6%
1Y: -0.5%
3Y: -99.0%
5Y: -100.0%
$1.47
Last traded 2026-04-06 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$2M
Revenue
-48.1% YoY
$483M
Net Income
+14444.0% YoY
$65M
Free Cash Flow
+999.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE735.3%
ROA719.3%
ROIC-36.5%
Valuation
P/E0.1
P/B0.4
EV/EBITDA-1.2
Leverage
Debt/Equity0.00
Current Ratio29.98
Interest Cov.-51.5x
Quality Scores
Piotroski F4/9
Altman Z126.36
Beneish M0.00